FY2026 Earnings Forecast for ARWR Issued By Leerink Partnrs
Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Free Report) – Equities research analysts at Leerink Partnrs cut their FY2026 earnings per share (EPS) estimates for Arrowhead Pharmaceuticals in a report released on Tuesday, March 18th. Leerink Partnrs analyst M. Foroohar now forecasts that the biotechnology company will post earnings of ($0.92) per share for the year, down […]
Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Free Report) – Equities research analysts at Leerink Partnrs cut their FY2026 earnings per share (EPS) estimates for Arrowhead Pharmaceuticals in a report released on Tuesday, March 18th. Leerink Partnrs analyst M. Foroohar now forecasts that the biotechnology company will post earnings of ($0.92) per share for the year, down […]
